Description
IGF::CL::IGF RADIOPHARMACEUTICALS
First action · last action
2017-08-31 · 2017-08-31
Transactions
1
First transaction's obligation
$134,724
Base + all options value (sum of deltas)
$393,326
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-08-31+$134,724= $134,724
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-08-31 | +$134,724 | $134,724 | IGF::CL::IGF RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CETPVZL5RQS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0409 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C24826N0693 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $111,150 | FY2026 |
| 36C25226N0456 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C26326F0080 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25726N0272 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $257,789 | FY2026 |
| 36C25726D0056 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 3650 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24823N0035 | CARDINAL HEALTH 414, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $105,612 | FY2023 |
| 36C24820F0103 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $86,048 | FY2020 |
| 36C24819N1050 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $78,932 | FY2019 |
| VA24817F2026 | ASTELLAS PHARMA US, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $243,162 | FY2017 |
| VA24816F2532 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $2,849 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24817C0163_3600_-NONE-_-NONE- · retrieved 2026-09-26.